September 12, 2026
Sam Altman told TechCrunch this week that taking OpenAI public in 2026 would be a mistake, even though the company has already filed confidentially for an eventual listing. That's a notable walk-back of the market's assumption that OpenAI was racing toward Wall Street. It isn't -- not yet, anyway.
Here's why that matters if you're a business evaluating AI vendors rather than a Wall Street analyst: a private OpenAI is a less predictable OpenAI. Public companies face quarterly discipline -- guidance, earnings calls, shareholder lawsuits if they overpromise. A company that can delay going public on its own timeline can also delay disclosing the messy parts of its business: compute costs, model reliability issues, the real economics behind those enterprise deals. Altman framed the delay as prudence, and it might well be. But it's also a signal that OpenAI isn't ready for the scrutiny that comes with public markets, which should make procurement teams ask harder questions about financial stability before signing multi-year contracts. Anyone doing a serious buy vs. build evaluation should weigh vendor durability as heavily as feature lists -- a tool you can't leave easily is a bet on that vendor's staying power, IPO or no IPO.
Anthropic's Dario Amodei has reportedly floated a plan to slow the pace of frontier AI development, and TechCrunch notes that Altman has voiced something similar. On its face, that sounds like exactly the kind of self-restraint critics have demanded from the two labs racing hardest to build the most capable models. I'd like to believe it. I also think it's fair to ask what 'pacing' means in practice when both companies are simultaneously fundraising, hiring, and shipping new products at a pace that shows no real sign of slowing.
The uncomfortable truth is that neither company controls the frontier alone. Google, Meta, and a growing list of well-funded Chinese labs aren't bound by any informal pacing agreement between Amodei and Altman. If OpenAI and Anthropic actually throttle back while competitors don't, they risk ceding ground -- which means any real slowdown probably requires either genuine coordination across the whole industry or regulation with teeth, not a handshake between two CEOs who are also rivals for the same enterprise customers. That tension is worth remembering the next time either company talks about safety as a shared value rather than a competitive one.
For most companies reading this, the IPO timeline and the pacing debate are boardroom dramas happening several floors above where you actually work. But they still matter, because they tell you something about how much you should lean on any single frontier lab. If the two most important AI companies in the world are simultaneously talking about caution and continuing to move fast, that's a sign the underlying technology and the business model around it are still being figured out in real time -- not a settled foundation you should build your entire operation on. That's part of why tools built to let you own your own workflows, rather than rent someone else's roadmap, hold up better regardless of what OpenAI or Anthropic decide next quarter -- whether that's through an AI app builder or simply picking platform tools you can adapt as the frontier labs' plans shift under you.
Which story do you think is more believable: Altman's caution about going public, or Amodei's talk of pacing the frontier -- and does either change how you'd bet on these companies as long-term vendors?
Sources